Effects of deoxyspergualine on chronic transplant nephropathy.
Nagano
T
T
Department of Urology, Kinki University School of Medicine, Osaka, Japan.
Uemura
T
T
Kanda
H
H
Akiyama
T
T
Kurita
T
T
D001379:Azathioprine / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D002908:Chronic Disease; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D006146:Guanidines / Q000627:therapeutic use*; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015850:Interleukin-6 / Q000097:blood; D016030:Kidney Transplantation / Q000276:immunology / Q000473:pathology / Q000502:physiology*; D008297:Male; D011507:Proteinuria; D012263:Ribonucleosides / Q000627:therapeutic use; D013256:Steroids / Q000627:therapeutic use
D015415:Biomarkers; D006146:Guanidines; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D015850:Interleukin-6; D012263:Ribonucleosides; D013256:Steroids; C010052:mizoribine; D016572:Cyclosporine; D003404:Creatinine; D001379:Azathioprine; C037258:gusperimus